Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan G Sham

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
JAMA Surgery|November 19, 2025
Financial Hardship After Surgical ProceduresAlexandra Hernandez, Nina M Clark, Jamie Olapo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 2014
Glypican-3-targeting F(ab')2 for 89Zr PET of hepatocellular carcinomaJonathan G Sham, Forrest M Kievit, John R Grierson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2014
Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinomaJonathan G Sham, Forrest M Kievit, John R Grierson, et al.
Journal of Surgical Oncology|July 11, 2024
Evaluating surgeon communication of pancreatic cancer prognosis using the VitalTalk ADAPT frameworkLindsay K Dickerson, Trisha A Lipson, Sardar Shahmir B Chauhan, et al.
Annals of Surgical Oncology|November 6, 2022
Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate CancersNina M Clark, Emma A Roberts, Catherine Fedorenko, et al.
Advances in Radiation Oncology|March 31, 2025
Long-Term Survival Following Chemoradiation in Locoregional Recurrent Germline <i>ATM</i> Mutated Pancreatic Ductal AdenocarcinomaRachael A Safyan, Keven Zhang, Smith Apisarnthanarax, et al.
Plos One|May 6, 2014
Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatmentKendall C Shibuya, Vikas K Goel, Wei Xiong, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 21, 2021
Postoperative biliary anastomotic strictures after pancreaticoduodenectomyAmmar A Javed, Muhammad B Mirza, Jonathan G Sham, et al.
AJR. American Journal of Roentgenology|September 1, 2021
CT Radiomics-Based Preoperative Survival Prediction in Patients With Pancreatic Ductal AdenocarcinomaSeyoun Park, Jonathan G Sham, Satomi Kawamoto, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 8, 2018
The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional StudyJonathan G Sham, Aslam Ejaz, Michele M Gage, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
JAMA Surgery|November 19, 2025
Financial Hardship After Surgical ProceduresAlexandra Hernandez, Nina M Clark, Jamie Olapo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 2014
Glypican-3-targeting F(ab')2 for 89Zr PET of hepatocellular carcinomaJonathan G Sham, Forrest M Kievit, John R Grierson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2014
Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinomaJonathan G Sham, Forrest M Kievit, John R Grierson, et al.
Journal of Surgical Oncology|July 11, 2024
Evaluating surgeon communication of pancreatic cancer prognosis using the VitalTalk ADAPT frameworkLindsay K Dickerson, Trisha A Lipson, Sardar Shahmir B Chauhan, et al.
Annals of Surgical Oncology|November 6, 2022
Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate CancersNina M Clark, Emma A Roberts, Catherine Fedorenko, et al.
Advances in Radiation Oncology|March 31, 2025
Long-Term Survival Following Chemoradiation in Locoregional Recurrent Germline <i>ATM</i> Mutated Pancreatic Ductal AdenocarcinomaRachael A Safyan, Keven Zhang, Smith Apisarnthanarax, et al.
Plos One|May 6, 2014
Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatmentKendall C Shibuya, Vikas K Goel, Wei Xiong, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 21, 2021
Postoperative biliary anastomotic strictures after pancreaticoduodenectomyAmmar A Javed, Muhammad B Mirza, Jonathan G Sham, et al.
AJR. American Journal of Roentgenology|September 1, 2021
CT Radiomics-Based Preoperative Survival Prediction in Patients With Pancreatic Ductal AdenocarcinomaSeyoun Park, Jonathan G Sham, Satomi Kawamoto, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 8, 2018
The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional StudyJonathan G Sham, Aslam Ejaz, Michele M Gage, et al.
Pageof 4